FDA SLAMS Chips — Highest Risk Tag

The Food and Drug Administration just put potato chips in the same risk tier as tainted spinach and peanut butter: Class I.

Story Snapshot

Federal regulators elevated the Utz recall of select Zapp’s and Dirty chips to Class I, the highest risk level.
The recall is tied to a seasoning ingredient containing dry milk powder and a potential Salmonella risk; no illnesses have been reported.
More than 600,000 bags were pulled, with products shipped nationwide, raising exposure concerns.
Class I means a reasonable chance of serious harm or death if contamination exists, according to the FDA.

What Class I Really Signals, In Plain English

The Food and Drug Administration (FDA) uses three recall classes. Class I is the top tier for danger. The FDA reserves it for products that pose a reasonable risk of serious health problems or death.

That language is plain for a reason. Salmonella can hospitalize healthy adults and hit the very young, the elderly, and those with weak immune systems even harder. This label is not theater; it is designed to move both stores and shoppers now.

Utz first pulled the products in May and named exact flavors and sizes, including Zapp’s Bayou Blackened Ranch, Zapp’s Big Cheezy, Dirty Salt and Vinegar, and Dirty Sour Cream and Onion, among others. That kind of detail matters when you are standing in the snack aisle squinting at a shelf tag.

The Hill reported the recall now covers more than 600,000 bags and reached shoppers across the country. The scale alone explains why the FDA’s upgrade drew attention well beyond snack fans.

The Trigger: A Seasoning With Dry Milk Powder

Utz traced the concern to a seasoning that includes dry milk powder, a known risk ingredient in past outbreaks. The company said all affected seasoning batches tested negative for Salmonella before use, but it still pulled products out of caution.

That move fits a pattern: many high-risk recalls start on a potential, not a confirmed, hit. The FDA later raised the classification to Class I, which The Hill noted occurred almost two months after the company’s first move.

Some readers will ask how a “negative” test ends up in a Class I recall. Food safety experts would point to sampling limits. You do not test every single particle of powder.

A negative result lowers odds; it does not erase them. When ingredients travel far and end up in large batches, small gaps in testing can lead to real exposure. The FDA’s own recall playbooks also show that “no illnesses reported” is normal copy in serious recall notices.

No Confirmed Illnesses, Real Stakes

Officials and the company say no illnesses have been linked to these chips so far. That is good news. It does not cancel the risk. The FDA says Class I does not wait on hospital beds to fill; it kicks in when the path to harm is reasonable.

Waiting for sick kids to prove a point would be reckless. Pull the product, warn the public, and then prove the negative with time and monitoring, not with patients.

Consumer trust often hinges on two things: clarity and speed. Utz named the flavors and sizes so buyers can check their pantries. The Hill’s report highlighted the large volume and wide reach, which place greater pressure on retailers to clear shelves quickly.

The broader record shows why regulators lean hard on biological risks. An analysis of two decades of recalls found that biological contamination and allergens drive almost all Class I actions, with Salmonella and Listeria accounting for a large share. That history supports a firm hand now.

What To Do Next And What To Watch

Shoppers should check bags against the listed varieties and sizes, then toss or return any match for a refund. People at higher risk, like seniors and those with weak immune systems, should be strict here.

For the bigger picture, watch for three updates: whether investigators name the dry milk powder supplier, whether any retained samples later test positive, and whether the Centers for Disease Control and Prevention logs any linked cases. Those facts would confirm or narrow the current risk window.

Some will frame this as regulators overreacting because no one is sick. The facts argue otherwise. The FDA defines Class I by probability and consequence, not by headlines after the fact. Utz moved first, named products, and pulled stock; the FDA then raised the risk level as details came in.

That sequence is not comforting, but it is how the system often works. Food safety is about speed against uncertainty. In that race, caution beats regret every time.